If mesenchymal stem cells are the messengers, exosomes are the messages. They are among the most actively researched topics in regenerative science right now, and also among the most poorly explained in clinic brochures.
What an exosome actually is
An exosome is an extracellular vesicle — a tiny membrane-bound package, typically between 30 and 150 nanometers across, released by a living cell. For scale, roughly a thousand of them laid end to end would span the width of a human hair. They are not cells. They cannot divide, and they do not become tissue.
What they carry is the point. Inside and on the surface of each vesicle are proteins, lipids, growth factors, and genetic material including messenger RNA and microRNA. When an exosome reaches another cell, that cargo is delivered — which is why researchers describe exosomes as a cell-to-cell communication system.
Exosomes vs. stem cells
- Stem cells are living cells that respond dynamically to their environment over time. Exosomes are acellular — a fixed payload with no metabolism of its own.
- Stem cells produce exosomes continuously as part of how they signal. Exosome products isolate that signaling fraction directly.
- Because exosomes are not living cells, handling, storage, and shelf-life considerations differ from cellular products.
- The two are not interchangeable, and one is not a discount version of the other.
Why sourcing matters even more here
Exosome products vary enormously in quality, and the variation is invisible to the patient. Particle count, purity, the tissue the parent cells came from, and how the product was isolated all change what is actually in the vial. Ask which laboratory produced it, whether that lab is FDA-registered, and whether the product is manufactured in the United States.
Exosome products are not FDA-approved to treat, cure, mitigate, or prevent any disease. Research remains ongoing and individual results vary. A licensed clinical provider determines whether any option is appropriate for you.
How exosome IV is offered here
Exosome IV is available at Stem Cell RX as a $1,000 option that can be added to a treatment plan when your provider determines it is appropriate. It is priced openly, like everything else we offer, and it is never bundled into a quote without being itemized. You will see the line and the number before you decide anything.
Questions to bring to a consultation
- Is an exosome option appropriate for my situation at all?
- What is the source tissue and the producing laboratory?
- What exactly is included in the quoted price, line by line?
- What should I realistically expect, and over what time frame?
Every patient must complete a clinical evaluation with a licensed healthcare professional to determine whether therapy is appropriate. Treatment is not recommended for all individuals.
Frequently asked questions
- Are exosomes FDA-approved?
- No. Exosome products are not FDA-approved for the treatment, cure, mitigation, or prevention of any disease.
- Can exosomes be combined with an MSC plan?
- Yes, when a licensed provider determines it is appropriate. The exosome IV add-on is $1,000.
- How are exosomes given?
- Most commonly by IV. Your provider will discuss the route that fits your evaluation.
Keep exploring Stem Cell RX
- Add an exosome IV to your plan$1,000 when your provider determines it is appropriate.
- What we administerProduct sourcing and testing details.
- What MSC stem cells areStart here if you are new to the terminology.
Independent sources
- PubMed — extracellular vesicle researchPrimary literature on exosomes and extracellular vesicles.
- FDA — Cellular & Gene Therapy ProductsRegulatory context for biologic products in the U.S.
- ClinicalTrials.govRegistered studies involving exosome-based products.
